BioRestorative Therapies Analyst Ratings
BioRestorative Therapies Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 486.99% | Roth MKM | → $15 | Reiterates | Buy → Buy |
| 12/07/2022 | 486.99% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 09/28/2022 | 134.8% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
| 12/01/2021 | 1347.91% | Roth Capital | → $37 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/14/2023 | 486.99% | Roth MKM | → 15 美元 | 重申 | 购买 → 购买 |
| 2022 年 7 月 12 日 | 486.99% | 罗斯资本 | → 15 美元 | 启动覆盖开启 | → 购买 |
| 2022 年 9 月 28 日 | 134.8% | Maxim 集团 | → 6 美元 | 启动覆盖开启 | → 购买 |
| 12/01/2021 | 1347.91% | 罗斯资本 | → 37 美元 | 启动覆盖开启 | → 购买 |
What is the target price for BioRestorative Therapies (BRTX)?
生物修复疗法（BRTX）的目标价格是多少？
The latest price target for BioRestorative Therapies (NASDAQ: BRTX) was reported by Roth MKM on August 14, 2023. The analyst firm set a price target for $15.00 expecting BRTX to rise to within 12 months (a possible 486.99% upside). 3 analyst firms have reported ratings in the last year.
Roth MKM于2023年8月14日公布了生物恢复疗法（纳斯达克股票代码：BRTX）的最新目标价格。该分析公司将目标股价定为15.00美元，预计BRTX将在12个月内升至12个月内（可能上涨486.99％）。去年有3家分析公司公布了评级。
What is the most recent analyst rating for BioRestorative Therapies (BRTX)?
分析师对生物修复疗法（BRTX）的最新评级是多少？
The latest analyst rating for BioRestorative Therapies (NASDAQ: BRTX) was provided by Roth MKM, and BioRestorative Therapies reiterated their buy rating.
生物恢复疗法（纳斯达克股票代码：BRTX）的最新分析师评级由Roth MKM提供，BioRestorative Therapis重申了买入评级。
When is the next analyst rating going to be posted or updated for BioRestorative Therapies (BRTX)?
生物修复疗法（BRTX）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioRestorative Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioRestorative Therapies was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与生物恢复疗法的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。生物修复疗法的最新评级是在2023年8月14日提交的，因此你应该预计下一个评级将在2024年8月14日左右公布。
Is the Analyst Rating BioRestorative Therapies (BRTX) correct?
分析师对生物修复疗法 (BRTX) 的评级是否正确？
While ratings are subjective and will change, the latest BioRestorative Therapies (BRTX) rating was a reiterated with a price target of $0.00 to $15.00. The current price BioRestorative Therapies (BRTX) is trading at is $2.56, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的生物修复疗法（BRTX）评级，目标价为0.00美元至15.00美元。生物恢复疗法（BRTX）目前的交易价格为2.56美元，在分析师的预测区间内。